Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- IVD Trends to Watch: Breakthroughs in Histology and Cytology July 10, 2024
- Cell and Gene Therapy Investments Reach $5 Billion in Q1 2024, $35 Billion Total in 2023 July 9, 2024
- IVD Trends to Watch: The Evolution of Point-of-Care (POC) Diagnostic Testing June 14, 2024
- IVD Trends to Watch: AI and the Future of Digital Pathology May 28, 2024
- Dynamic Landscape for Cell and Gene Therapy in 2024 May 22, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
The Wide-Reaching Potential of Artificial Intelligence in Healthcare
This blog is based on the August 2023 market research report The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition, now on sale from Kalorama Information Artificial intelligence systems, which simulate human intelligence by learning, reasoning, and self-correction, have the potential to be more accurate than doctors at making diagnoses and performing surgical interventions. […]
IVD for Pets: A $2.7 Billion Global Market
The need for veterinary testing has grown in recent years, as the majority of U.S. households claim to have at least one pet in the family. This has created ample opportunity for the companion animal segment of the veterinary diagnostic market, which globally had sales of $2.7 billion in 2022. The findings are according to […]
U.S. Consumer Out-of-Pocket Healthcare Spending to Grow 10% Annually Through 2028
Out-of-pocket expenditures (OOP) have long weighed upon the United States healthcare system and consumers. The weight is as heavy as ever in 2023 as OOP healthcare spending by consumers will reach an estimated $519 billion by year’s end, up almost 9% from 2022 with continued annual growth of 10% forecast through 2028. These findings are […]
Saudi Arabia IVD Market Rose to $605 Million in 2022, 3.8% CAGR Forecast
The market for in vitro diagnostics (IVDs) in Saudi Arabia, a young country in an aging world, reached an estimated $605 million in 2022, according to Kalorama Information’s 30-Country IVD Market Atlas. In 2022, the market was driven in part by COVID-19 testing, with about 44 million PCR COVID-19 tests performed through last August. Looking ahead, […]
Cell and Gene Therapy Funding Totaled $40 Billion in 2022, Growth Projected
Cell and gene therapy is attracting much attention these days and for good reason. For one, there has been a notable increase in the number of cell and gene therapies in clinical development over the past decade. In the United States alone there are over 1,000 cell and gene therapies in clinical development, and more […]
It’s 2023: Where is the At-Home IVD Testing Market Now?
The Home IVD testing market is not new, but it had primarily been limited to glucose and pregnancy testing. COVID-19 testing has opened the door for home infectious disease testing and more. The market is detailed in Kalorama’s latest report At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023 https://kaloramainformation.com/product/at-home-diagnostic-testing-markets-and-trends-covid-19-fob-glucose-hiv-and-other-tests-2023/ The global Home IVD testing market was […]
New Kalorama Report Pegs Clinical Lab Services Market at 168BN
The global market for clinical laboratory services grew to an estimated $168.3 billion during 2022. This is according to Kalorama’s latest report on clinical lab services (https://kaloramainformation.com/product/clinical-laboratory-services-market-8th-edition/) The COVID-19 testing demand increased the market by more than $31 billion over the year. Besides the remarkable and continued growth in 2022 due to COVID-19 demand, there are a number of […]
WHO Reports Lowered Threat Level of COVID-19; What Does it Mean for Testing?
Three years and more than seven million casualties later, the COVID-19 pandemic is officially no longer a global health emergency, according to a recent statement by the World Health Organization (WHO). Dr. Tedros Adhanom Ghebreyesus, director general of WHO, announced COVID-19’s less severe designation in early May, though the decision had been carefully considered for […]
SDi Releases Flagship Market Research Report on Analytical and Life Science Instruments: The Global Assessment Report
The definitive market reference tool for the analytical and life science instrumentation industry is officially here. The SDi Global Assessment Report 2023 is the latest edition in the bestselling market research report series published annually by Strategic Directions International (SDi), the leading business intelligence firm focused on analytical and life science instruments. SDi is a […]
Despite Declines, COVID-19 Still a Large IVD Market
When a market declines in momentum, it’s easy to forget that it still contributes to the overall market. This is the case with COVID-19. Testmakers are separating revenues to be sure investors know the parts of their business growing and declining and what part is related to the now-endemic disease. However, this belies the fact […]